Form 4: Novo Holdings A/S Sells Shares of IO Biotech, Inc.

Novo Holdings A/S, a major shareholder of IO Biotech, Inc., sold 658,809 shares of common stock at a price of $1.2181 per share on May 10, 2024.

Summary

• On May 10, 2024, Novo Holdings A/S sold 658,809 shares of IO Biotech, Inc. common stock.
• The sale price was $1.2181 per share.
• Following the transaction, Novo Holdings A/S directly owns 4,429,449 shares of IO Biotech, Inc.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the sale of shares by a major shareholder, which could indicate a lack of confidence or a strategic portfolio adjustment.

Negatives

• Novo Holdings A/S, a significant shareholder, has reduced its stake in IO Biotech, Inc. by selling 658,809 shares.

Risks

• The sale of shares by a major shareholder like Novo Holdings A/S could potentially create downward pressure on the stock price of IO Biotech, Inc.

Industry Context

Sales of shares by major holders are common and can be for a variety of reasons, including portfolio rebalancing or to realize gains. The impact on the stock price depends on market perception and the overall health of the company.

Stakeholder Impact

• Shareholders may react to the news of the share sale, potentially impacting the stock price.
• The company's reputation could be affected depending on the market's interpretation of the sale.

Key Dates